Please login to the form below

Not currently logged in
Email:
Password:

Trio of wins for Leo Pharma at PMEA

Takes small company of the year, launch excellence and patient services awards

PMEA 2012 Leo Pharma

Leo Pharma UK picked up three awards at last night's PMEAs (Pharmaceutical Market Excellence Awards), including the prize for small company of the year.

Leo's Princes Risborough-based affiliate beat Celgene and Astellas to take home the award for best company with a turnover under £150m, thanks to the way it transformed its approach to marketing and business.

"The transformation from traditional corporation to foundation has led to Leo reinvesting profits into development and impressive new talent being attracted to the organisation,” the PMEA judges said.

They added: “There is a sense of significant achievement within the company, and it's great to see the UK entity taking a lead within the entire organisation, with their truly multifunctional methodology being adopted throughout LEO Pharma."

There were further triumphs for Leo at the 2012 PMEAs, with a win (in association with Langland) in the Saatchi & Saatchi Health Award for Launch Excellence.

The company's UK launch of Dovobet Gel (calcipotriol/betamethasone dipropionate) for psoriasis in January 2011 was the largest in the history of dermatology.

The judges felt the company produced “a really comprehensive campaign that clearly showed they had done their homework”, recognising the issues that patients and their GPs faced in understanding the condition and its treatment.

Leo also picked up the Excellence in Provision of Patient Services, this time in association with Atlantis Healthcare, for its 'touch' Patient Support Programme.

In conjunction with health psychologists, dermatologists and patients, Leo developed 'touch' – an evidence-based support programme designed to improve adherence and health outcomes for people living with psoriasis. 

Available to everyone with psoriasis aged over 18 in the UK (and their loved ones), users can access the 'touch' website and helpline, and also receive belief-based interventional content through a variety of media channels. 

See the full results of PMEA 2012
See a gallery of all the winners at PMEA 2012

30th November 2012

From: Sales

Share

Tags

Featured jobs

Head of Commercial Training Strategy (m/ f)
On application
Marketing Manager - Pharmaceuticals, Northern UK
Excellent Salary & Benefits
UK Marketing Director
80,000 to 100,000 per annum
Medical Writer / Editor – LONDON
DOE

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Established in 1993, Atlantis Healthcare provides unique solutions to address the issues of treatment non-adherence and patient self-management....

Latest intelligence

What IF (Indigenus Forum) Meeting Report
IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
Multichannel_capability_development_case_study_-_PMLive.png
Developing multichannel capability in Pharma
Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...
Deal Watch table
Deal Watch table for May 2013
Table listing all the major pharma mergers, acquisitions and collaborations in the past month...